<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200613047756N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-07-19</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of auriculotherapy on sleep quality</public_title>
      <acronym></acronym>
      <scientific_title>The effect of auriculotherapy on sleep quality in postmenopausal women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-01-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>41</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/48893</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: After selecting the research units, the individuals will be randomly assigned 1: 1 in blocks of 4. In order to hide the allocation, envelopes will be used in the matte package, which are numbered in order and the type of intervention is written inside them.These envelopes will be prepared by the researcher involved in collecting data that is not known from the research, Blinding description: In order to hide the allocation, envelopes will be used in matte packages, which are numbered in order and the type of intervention is written inside them. These envelopes will be prepared by a non-involved researcher in data collection.</study_design>
      <phase>N/A</phase>
      <hc_freetext>sleep disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  In this experiment, using an Excel 2 AUrycolotherapy device made in China, the main points related to sleep in the right ear are stimulated for 15 seconds, The plantar warts are then attached to the irritated spots of Vakaria, and it is recommended that the person be pressured for one minute every hour except for bedtime and return after 6 days. The duration of the intervention was 4 weeks. Intervention 2: Control group: n this experiment, using an Excel 2 Aurycolotherapy device made in China, the false spots on the back of the right ear are stimulated for 15 seconds.Then, on the irritated areas, the plantar fissures of Vakaria are glued without a nut, and it is recommended that the person press the seedlings for one minute every hour, except for bedtime, and return after 6 days. The intervention period was 4 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All Study data includes primary and secondary outcomes and other study data after non-identifiable shareable individuals.

When:
Study data will be available 6 months after the results are published.

To whom:
Other study documents should be made available to the public.

Conditions:
Individuals with the name of the study researcher are allowed to use the study documents, individuals are not allowed to analyze any of the submitted data.

Where to obtain:
To receive the documents, people can contact the following mailing address: m.eidany1363@gmail.com

How to obtain:
The applicant of these documents will respond to the request within 24 hours after the request is sent via e-mail, and the relevant files will be provided to the applicant.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mona Eidani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>North Abuzar Alley 10, Sadat St, Taleghani Town</address>
        <city>Mahshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>63531-96474</zip>
        <telephone>+98 61 5244 0028</telephone>
        <email>m.eidany1363@gmail.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mona Eidani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>North Abuzar Alley 10, Sadat St, Taleghani Town</address>
        <city>Mahshar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>63531-96474</zip>
        <telephone>+98 61 5244 0028</telephone>
        <email>m.eidany1363@gmail.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Amenorrhea for at least 12 months
Ages 60-45
Get a score of more than 5 from the Pittsburgh Questionnaire</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>60 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having a known underlying disease (heart, kidney, thyroid, hypertension, diabetes, etc.)
The emergence of any physical or mental illness during research that causes sleep disorders
Use of hormone therapy, Armatase inhibitors, clonidine and antidepressants, sleeping pills during the last three months and during the study
Consumption of alcohol and addictive substances and tobacco
Severe uterine bleeding
Loss of a relative during the last 6 months and during the study
Use of other traditional therapies and complementary medicine in the last 4 weeks during the study
Emergence of significant change in unpredictable sleep conditions, including travel, relocation
Take any herbal or chemical sleeping pills
Having edema and inflammation in both ears</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G47	G47.0 </hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>VI Diseases of the nervous system , Sleep disorders ,  Disorders of initiating and maintaining sleep [insomnias], Disorders of excessive somnolence [hypersomnias]  Disorders of the sleep-wake schedule. Sleep apnoea ,Narcolepsy and cataplexy , Other sleep </hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  In this experiment, using an Excel 2 AUrycolotherapy device made in China, the main points related to sleep in the right ear are stimulated for 15 seconds, The plantar warts are then attached to the irritated spots of Vakaria, and it is recommended that the person be pressured for one minute every hour except for bedtime and return after 6 days. The duration of the intervention was 4 weeks.</i_keyword>
      <i_keyword>Control group: n this experiment, using an Excel 2 Aurycolotherapy device made in China, the false spots on the back of the right ear are stimulated for 15 seconds.Then, on the irritated areas, the plantar fissures of Vakaria are glued without a nut, and it is recommended that the person press the seedlings for one minute every hour, except for bedtime, and return after 6 days. The intervention period was 4 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sleep quality score in the Pittsburgh questionnaire. Timepoint: Completion of the questionnaire then 4 weeks of intervention with the Auriculotherapy device and re-completion of the questionnaire. Method of measurement: Pittsburgh Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Sleep Mental Quality Score in the Pittsburgh Questionnaire. Timepoint: Completion of the questionnaire, then 4 weeks of intervention with the Auricotherapy device, then re-completion of the questionnaire. Method of measurement: Pittsburgh Questionnaire.</sec_outcome>
      <sec_outcome>Sleep efficiency score on the Pittsburgh questionnaire. Timepoint: Completion of the questionnaire, then 4 weeks of intervention with the Auricotherapy device, then re-completion of the questionnaire. Method of measurement: Pittsburgh Questionnaire.</sec_outcome>
      <sec_outcome>Daily Performance Disorder Score in the Pittsburgh Questionnaire. Timepoint: Completion of the questionnaire, then 4 weeks of intervention with the Auricotherapy device, then re-completion of the questionnaire. Method of measurement: Pittsburgh Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-06-10</approval_date>
        <contact_name>Ethics Committee of Ahvaz University of Medical Sciences</contact_name>
        <contact_address>North Abuzar Ally 10, Sadat St, Taleghani Town Mahshahr Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
